Lineage Cell Therapeutics
Price & Volume
Stats
See more52W Range | $0.47-$1.56 |
Market Cap | $117.6M |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $9.4M |
Revenue Growth (YoY) | 37.4% |
Gross Profit (12 Mos) | -$3.3M |
Diluted EPS | -$0.09 |
News
See moreYahoo Finance • 2 years ago
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2023 Earnings Call Transcript
Yahoo Finance • 2 years ago
Lineage Cell Therapeutics Appoints Jill Howe as Chief Financial Officer
Yahoo Finance • 3 years ago
Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Yahoo Finance • 3 years ago
Lineage Cell Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
About
CEO | Mr. Brian M. Culley M.A., M.B.A. |
CFO | Ms. Jill Ann Howe |
Address | 2173 Salk Avenue, Carlsbad, CA, United States, 92008 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 70 |
